Replies to post #114083 on Biotech Values

[sodrock]

10nis,

You seem to forget that while MNTA only has ONE drug right now.. Hospitals purchase MANY drugs from TEVA, thousands of dollars worth; the accounts now lost 6 months worth of savings while waiting for TEVA on empty promises (you are talking millions for the HCA hospital network). And on top of that TEVA isn't delivering on promises with back orders of current medications. And you don't think institutions aren't going to feel slighted by TEVA? Get real, hospitals have real people working in them with real emotions with REAL budgets.

That is BAD business and yes many institutions are upset by this. Why would they now go from M-enox to T-enox when approved? Bad move by TEVA imo

[y3maxx]

"Paranoid, think about it"

10nisman

""I think if MNTA weren't going after Copaxone, TEVA would have scrapped T-enox already.""

sodrock



...From my Pov, Teva was/is/remains concerned/paranoid about an M copax approval.

Limiting MNTA & M enox's credibility was just the start of their gameplan.

y3